Yes. PGT-A is performed in addition to PGT-SR or PGT-M, and for couples at risk for more than one disease, PGT-M for multiple diseases can be performed.  In addition to the known genetic disease(s), biopsied embryos are screened for chromosomal aneuploidy. Only embryos unaffected (or a silent carrier) for the genetic disease and with a normal chromosome result would be considered available for transfer. Whether to use or not use embryos that are carriers of an autosomal recessive or X-linked disease will be discussed with each patient. The combination of PGT-M for genetic disease and PGT-A for aneuploidy screening will help identify the best embryo(s) to use with the greatest chance for a healthy outcome.